Lee S K, Klinger H, Mueller T. "一种的合成方法" [P]. US Patent, US 11253113 B2, 2024-11-15.
发明人黄志刚,郭海燕,朱建伟. "Method for the Synthesis of 4-Acetyl-5-chloro-2-(4-methoxybenzyl)pyridazin-3(2H)-one" [P]. 中国发明专利, 专利号 CN 109632036 B, 授权公告日 2015-10-02.
Brown S R, Davis P L, Fischer A B. "A Process for Preparing High-Purity 4-Acetyl-5-chloro-2-(4-methoxybenzyl)pyridazin-3(2H)-one" [P]. US Patent, US 10016313 B2, 2018-02-26.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2022, 932, (1), 9029-9035.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2019, 1305, (3), 1995-2014.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 4-Acetyl-5-chloro-2-(4-methoxybenzyl)pyridazin-3(2H)-one Using HRMS and NMR". Chromatographia, 2023, 2361, 6214-6232.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2018, 878, 2388-2402.